性感染症治療薬の世界市場 2020年

• 英文タイトル：Global Sexually Transmitted Disease Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115116 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、性感染症治療薬の世界市場を調査対象にし、性感染症治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（淋病、梅毒、クラミジア、トリコモナス症）、用途別分析（病院、診断研究所、研究・学術研究所、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Abbott、BioMérieux、Roche、BD、Cepheid、Bio-Rad ・企業別売上、市場シェア ・性感染症治療薬の地域別市場分析 ・性感染症治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・性感染症治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・性感染症治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・性感染症治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・性感染症治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・性感染症治療薬の種類別市場規模2015-2020：淋病、梅毒、クラミジア、トリコモナス症 ・性感染症治療薬の用途別市場規模2015-2020：病院、診断研究所、研究・学術研究所、その他 ・性感染症治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Sexually Transmitted Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Sexually Transmitted Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Sexually Transmitted Disease Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Sexually Transmitted Disease Therapeutics market has been segmented into:
Gonorrhea
Syphilis
Chlamydia
Trichomoniasis

By Application, Sexually Transmitted Disease Therapeutics has been segmented into:
Hospitals
Diagnostic Laboratories
Research and Academic Laboratories
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sexually Transmitted Disease Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Sexually Transmitted Disease Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sexually Transmitted Disease Therapeutics market.

The report offers in-depth assessment of the growth and other aspects of the Sexually Transmitted Disease Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Sexually Transmitted Disease Therapeutics Market Share Analysis
Sexually Transmitted Disease Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sexually Transmitted Disease Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sexually Transmitted Disease Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in Sexually Transmitted Disease Therapeutics are:
Abbott
BioMérieux
Roche
BD
Cepheid
Bio-Rad

レポート目次

---

1 Sexually Transmitted Disease Therapeutics Market Overview
1.1 Product Overview and Scope of Sexually Transmitted Disease Therapeutics
1.2 Classification of Sexually Transmitted Disease Therapeutics by Type
1.2.1 Global Sexually Transmitted Disease Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Type in 2019
1.2.3 Gonorrhea
1.2.4 Syphilis
1.2.5 Chlamydia
1.2.6 Trichomoniasis
1.3 Global Sexually Transmitted Disease Therapeutics Market by Application
1.3.1 Overview: Global Sexually Transmitted Disease Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research and Academic Laboratories
1.3.5 Others
1.4 Global Sexually Transmitted Disease Therapeutics Market by Regions
1.4.1 Global Sexually Transmitted Disease Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sexually Transmitted Disease Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sexually Transmitted Disease Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sexually Transmitted Disease Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sexually Transmitted Disease Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sexually Transmitted Disease Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sexually Transmitted Disease Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott SWOT Analysis
2.1.4 Abbott Product and Services
2.1.5 Abbott Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 BioMérieux
2.2.1 BioMérieux Details
2.2.2 BioMérieux Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 BioMérieux SWOT Analysis
2.2.4 BioMérieux Product and Services
2.2.5 BioMérieux Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 BD
2.4.1 BD Details
2.4.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BD SWOT Analysis
2.4.4 BD Product and Services
2.4.5 BD Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cepheid
2.5.1 Cepheid Details
2.5.2 Cepheid Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cepheid SWOT Analysis
2.5.4 Cepheid Product and Services
2.5.5 Cepheid Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bio-Rad
2.6.1 Bio-Rad Details
2.6.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bio-Rad SWOT Analysis
2.6.4 Bio-Rad Product and Services
2.6.5 Bio-Rad Sexually Transmitted Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sexually Transmitted Disease Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sexually Transmitted Disease Therapeutics Players Market Share
3.2.2 Top 10 Sexually Transmitted Disease Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sexually Transmitted Disease Therapeutics Revenue and Market Share by Regions
4.2 North America Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Sexually Transmitted Disease Therapeutics Revenue by Countries
5.1 North America Sexually Transmitted Disease Therapeutics Revenue by Countries (2015-2020)
5.2 USA Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Sexually Transmitted Disease Therapeutics Revenue by Countries
6.1 Europe Sexually Transmitted Disease Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue by Countries
7.1 Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue by Countries (2015-2020)
7.2 China Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Sexually Transmitted Disease Therapeutics Revenue by Countries
8.1 South America Sexually Transmitted Disease Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sexually Transmitted Disease Therapeutics by Countries
9.1 Middle East & Africa Sexually Transmitted Disease Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sexually Transmitted Disease Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Sexually Transmitted Disease Therapeutics Market Forecast by Type (2019-2024)
10.3 Gonorrhea Revenue Growth Rate (2015-2025)
10.4 Syphilis Revenue Growth Rate (2015-2025)
10.5 Chlamydia Revenue Growth Rate (2015-2025)
10.6 Trichomoniasis Revenue Growth Rate (2015-2025)
11 Global Sexually Transmitted Disease Therapeutics Market Segment by Application
11.1 Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Sexually Transmitted Disease Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Research and Academic Laboratories Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Sexually Transmitted Disease Therapeutics Market Size Forecast (2021-2025)
12.1 Global Sexually Transmitted Disease Therapeutics Market Size Forecast (2021-2025)
12.2 Global Sexually Transmitted Disease Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Sexually Transmitted Disease Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sexually Transmitted Disease Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sexually Transmitted Disease Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sexually Transmitted Disease Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott Corporate Information, Location and Competitors
Table 6. Abbott Sexually Transmitted Disease Therapeutics Major Business
Table 7. Abbott Sexually Transmitted Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Abbott SWOT Analysis
Table 9. Abbott Sexually Transmitted Disease Therapeutics Product and Solutions
Table 10. Abbott Sexually Transmitted Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. BioMérieux Corporate Information, Location and Competitors
Table 12. BioMérieux Sexually Transmitted Disease Therapeutics Major Business
Table 13. BioMérieux Sexually Transmitted Disease Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. BioMérieux SWOT Analysis
Table 15. BioMérieux Sexually Transmitted Disease Therapeutics Product and Solutions
Table 16. BioMérieux Sexually Transmitted Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Roche Corporate Information, Location and Competitors
Table 18. Roche Sexually Transmitted Disease Therapeutics Major Business
Table 19. Roche Sexually Transmitted Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Roche SWOT Analysis
Table 21. Roche Sexually Transmitted Disease Therapeutics Product and Solutions
Table 22. Roche Sexually Transmitted Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. BD Corporate Information, Location and Competitors
Table 24. BD Sexually Transmitted Disease Therapeutics Major Business
Table 25. BD Sexually Transmitted Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. BD SWOT Analysis
Table 27. BD Sexually Transmitted Disease Therapeutics Product and Solutions
Table 28. BD Sexually Transmitted Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cepheid Corporate Information, Location and Competitors
Table 30. Cepheid Sexually Transmitted Disease Therapeutics Major Business
Table 31. Cepheid Sexually Transmitted Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Cepheid SWOT Analysis
Table 33. Cepheid Sexually Transmitted Disease Therapeutics Product and Solutions
Table 34. Cepheid Sexually Transmitted Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bio-Rad Corporate Information, Location and Competitors
Table 36. Bio-Rad Sexually Transmitted Disease Therapeutics Major Business
Table 37. Bio-Rad Sexually Transmitted Disease Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Bio-Rad SWOT Analysis
Table 39. Bio-Rad Sexually Transmitted Disease Therapeutics Product and Solutions
Table 40. Bio-Rad Sexually Transmitted Disease Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Sexually Transmitted Disease Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 42. Global Sexually Transmitted Disease Therapeutics Revenue Share by Players (2015-2020)
Table 43. Global Sexually Transmitted Disease Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Regions (2015-2020)
Table 45. North America Sexually Transmitted Disease Therapeutics Revenue by Countries (2015-2020)
Table 46. North America Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Table 47. Europe Sexually Transmitted Disease Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Sexually Transmitted Disease Therapeutics Revenue by Countries (2015-2020)
Table 50. South America Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Sexually Transmitted Disease Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Table 53. Global Sexually Transmitted Disease Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 54. Global Sexually Transmitted Disease Therapeutics Revenue Share by Type (2015-2020)
Table 55. Global Sexually Transmitted Disease Therapeutics Revenue Forecast by Type (2021-2025)
Table 56. Global Sexually Transmitted Disease Therapeutics Revenue by Application (2015-2020)
Table 57. Global Sexually Transmitted Disease Therapeutics Revenue Share by Application (2015-2020)
Table 58. Global Sexually Transmitted Disease Therapeutics Revenue Forecast by Application (2021-2025)
Table 59. Global Sexually Transmitted Disease Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sexually Transmitted Disease Therapeutics Picture
Figure 2. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Type in 2019
Figure 3. Gonorrhea Picture
Figure 4. Syphilis Picture
Figure 5. Chlamydia Picture
Figure 6. Trichomoniasis Picture
Figure 7. Sexually Transmitted Disease Therapeutics Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Research and Academic Laboratories Picture
Figure 11. Others Picture
Figure 12. Global Sexually Transmitted Disease Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Sexually Transmitted Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Sexually Transmitted Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Sexually Transmitted Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Sexually Transmitted Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Sexually Transmitted Disease Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Sexually Transmitted Disease Therapeutics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Sexually Transmitted Disease Therapeutics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Sexually Transmitted Disease Therapeutics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Sexually Transmitted Disease Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Sexually Transmitted Disease Therapeutics Revenue Market Share by Regions in 2018
Figure 26. North America Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. South America Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. North America Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 33. USA Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 38. Germany Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. UK Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. France Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 45. China Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. India Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. South America Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 52. Brazil Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Sexually Transmitted Disease Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Sexually Transmitted Disease Therapeutics Revenue and Growth Rate (2015-2020)
Figure 60. Global Sexually Transmitted Disease Therapeutics Revenue Share by Type (2015-2020)
Figure 61. Global Sexually Transmitted Disease Therapeutics Revenue Share by Type in 2019
Figure 62. Global Sexually Transmitted Disease Therapeutics Market Share Forecast by Type (2021-2025)
Figure 63. Global Gonorrhea Revenue Growth Rate (2015-2020)
Figure 64. Global Syphilis Revenue Growth Rate (2015-2020)
Figure 65. Global Chlamydia Revenue Growth Rate (2015-2020)
Figure 66. Global Trichomoniasis Revenue Growth Rate (2015-2020)
Figure 67. Global Sexually Transmitted Disease Therapeutics Revenue Share by Application (2015-2020)
Figure 68. Global Sexually Transmitted Disease Therapeutics Revenue Share by Application in 2019
Figure 69. Global Sexually Transmitted Disease Therapeutics Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 72. Global Research and Academic Laboratories Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Sexually Transmitted Disease Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Sexually Transmitted Disease Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Sexually Transmitted Disease Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Europe Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 80. South America Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Sexually Transmitted Disease Therapeutics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel

---